Eurofins BioPharma Newsletter- October 2022
Check out the latest Eurofins BioPharma Newsletter
New BioAnalysis Zone eBook
Check out this eBook detailing key methods in clinical vaccine development on BioAnalysisZone.com
Eurofins BioPharma Newsletter- June 2022
Check out the latest BioPharma Newsletter
ON-DEMAND WEBINAR Defining Specificity within the ELISpot Assay
February 23, 2022 11 am EST
On-Demand AVAILABLE "Defining Specificity within the ELISpot Assay" Presented by TJ Beadnell, PhD, Scientific Manager, R&D.
Eurofins BioPharma Newsletter- February 2022
ON DEMAND: Viral shedding and infectivity testing in clinical trials of Oncolytic virotherapy
VIEW ON DEMAND "Viral shedding and infectivity testing in clinical trials of Oncolytic virotherapy" presented by Kristen Mickey, Research Scientist, R&D.
Eurofins BioPharma Newsletter- October 2021
Check out the latest BioPharma Newsletter featuring how Eurofins Viracor targets precision oncology with the launch of PanCancer IQ™ and learn about new services and analytical techniques, research projects and other related topics.
Eurofins Viracor BioPharma Immunotherapy Force Multiplier
It was October 2015 when the US immunotherapy market was celebrating its first-ever FDA-approved oncolytic virus therapy, talimogene laherparepve (T-VEC). Developed by Amgen, this new genre of immunotherapy demonstrated immense efficacy in treating advanced melanoma.
Eurofins BioPharma Newsletter - June 2021
Check out the latest BioPharma Newsletter from the Eurofins Group to learn about new services and analytical techniques, research projects, major events and other related topics.
Eurofins BioPharma Newsletter - Feb 2021
Connect With Our Experts